Caspases determine the vulnerability of oligodendrocytes in the ischemic brain

Journal of Clinical Investigation

Volumn 106, Issue 5, 2000, Pages 643-653

  Shibata, Mamoru ^a,b   Hisahara, Shin ^a   Hara, Hideaki ^c   Yamawaki, Takemori ^d   Fukuuchi, Yasuo ^b   Yuan, Junying ^e   Okano, Hideyuki ^a,f   Miura, Masayuki ^a,f  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KEIO UNIVERSITY   (Japan)

^c SANTEN PHARMACEUTICAL CO LTD   (Japan)

^d NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^e HARVARD MEDICAL SCHOOL   (United States)

^f JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; CASPASE 3; PROTEIN P35;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN ISCHEMIA; CELL HYPOXIA; CONTROLLED STUDY; ENZYME ACTIVATION; MALE; MOUSE; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; STROKE;

EID: 0033817982     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI10203     Document Type: Article

References (51)

1. Pantoni, L., and Garcia, J.H. 1997. Pathogenesis of leukoaraiosis: a review. Stroke. 28:652-659.
2. Pantoni, L., et al. 1999. Role of white matter lesions in cognitive impairment of vascular origin. Alzheimer Dis. Assoc. Disord. 13(Suppl. 3):S49-S54.
3. Pantoni, L., Garcia, J.H., and Gutierrez, J.A. 1996. Cerebral white matter is highly vulnerable to ischemia. Stroke. 27:1641-1646; discussion 1647.
4. Mandai, K., et al. 1997. Ischemic damage and subsequent proliferation of oligodendrocytes in focal cerebral ischemia. Neuroscience. 77:849-861.
5. McDonald, J.W., Althomsons, S.P., Hyrc, K.L., Choi, D.W., and Goldberg, M.P. 1998. Oligodendrocytes from forebrain are highly vulnerable to AMPA/kainate receptor-mediated excitotoxicity. Nat. Med. 4:291-297.
6. Petito, C.K., Olarte, J.P., Roberts, B., Nowak, T.S., Jr., and Pulsinelli, W.A. 1998. Selective glial vulnerability following transient global ischemia in rat brain. J. Neuropathol. Exp. Neurol. 57:231-238.
7. Lyons, S.A., and Kertenmann, H. 1998. Oligodendrocytes and microglia are selectively vulnerable to combined hypoxia and hypoglycemia injury in vitro. J. Cereb. Blood Flow Metab. 18:521-530.
8. Nicholson, D.W., and Thornberry, N.A. 1997. Caspases: killer proteases. Trends Biochem. Sci. 22:299-306.
9. Hisahara, S., Shoji, S., Okano, H., and Miura, M. 1997. ICE/CED-3 family executes oligodendrocyte apoptosis by tumor necrosis factor. J. Neurochem. 69:10-20.
10. Gu, C., Casaccia-Bonnefil, P., Srinivasan, A., and Chao, M.V. 1999. Oligodendrocyte apoptosis mediated by caspase activation. J. Neurosci. 19:3043-3049.
11. Kuida, K., et al. 1996. Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice. Nature. 384:368-372.
12. Hakem, R., et al. 1998. Differential requirement for caspase 9 in apoptotic pathways in vivo. Cell. 94:339-352.
13. Kuida, K., et al. 1998. Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase 9. Cell. 94:325-337.
14. Choi, D.W. 1988. Glutamate neurotoxicity and diseases of the nervous system. Neuron. 1:623-634.
15. Rossi, D.J., Oshima, T., and Attwell, D. 2000. Glutamate release in severe brain ischaemia is mainly by reversed uptake. Nature. 403:316-321.
16. Beckman, J.S., and Koppenol, W.H. 1996. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am. J. Physiol. 271:C1424-C3437.
17. Friedlander, R.M., et al. 1997. Expression of a dominant negative mutant of interleukin-1 beta converting enzyme in transgenic mice prevents neuronal cell death induced by trophic factor withdrawal and ischemic brain injury. J. Exp. Med. 185:933-940.
18. Hara, H., et al. 1997. Attenuation of transient focal cerebral ischemic injury in transgenic mice expressing a mutant ICE inhibitory protein, J. Cereb. Blood Flow Metab. 17:370-375.
19. Gregersen, R., Lambertsen, K., and Finsen, B. 2000. Microglia and macrophages are the major source of tumor necrosis factor in permanent middle cerebral artery occlusion in mice. J. Cereb. Blood Flow Metab. 20:53-65.
20. Miura, M., Zhu, H., Rotello, R., Hartwieg, E.A., and Yuan, J. 1993. Induction of apoptosis in fibroblasts by IL-1 beta-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3. Cell. 75:653-660.
21. Kuida, K., et al. 1995. Altered cytokine export and apoptosis in mice deficient in interleukin-1 beta converting enzyme. Science. 267:2000-2003.
22. Sauer, B. 1998. Inducible gene targeting in mice using the Cre/lox system. Methods. 14:381-392.
23. Lobe, C.G., et al. 1999. Z/AP, a double reporter for cre-mediated recombination. Dev. Biol. 208:281-292.
24. Rabizadeh, S., LaCount, D.J., Friesen, P.D., and Bredesen, D.E. 1993. Expression of the baculovirus p35 gene inhibits mammalian neural cell death. J. Neurochem. 61:2318-2321.
25. Martinou, I., et al. 1995. Viral proteins E1B19K and p35 protect sympathetic neurons from cell death induced by NGF deprivation. J. Cell Biol. 128:201-208.
26. Villa, P., Kaufmann, S.H., and Earnshaw, W.C. 1997. Caspases and caspase inhibitors. Trends Biochem Sci. 22:388-393.
27. Hisahara, S., et al. 2000. Targeted expression of baculovirus p35 caspase inhibitor in oligodendrocytes protects mice against autoimmune-mediated demyelination. EMBO J. 19:341-348.
28. Viswanath, V., et al. 2000. Transgenic mice neuronally expressing baculoviral p35 are resistant to diverse types of induced apoptosis, including seizure-associated neurodegeneration. Proc. Natl. Acad. Sci. USA. 97:2270-2275.
29. Araki, T., et al. 2000. Conditional expression of anti-apoptotic protein p35 by Cre-mediated DNA recombination in cardiomyocytes from lox-P-p35-transgenic mice. Cell Death Differ. 7:485-492.
30. Wang, S., et al. 1998. Murine caspase-11, an ICE-interacting protease, is essential for the activation of ICE. Cell. 92:501-509.
31. Tansey, F.A., and Cammer, W. 1991. A pi form of glutathione-S-transferase is a myelin-and oligodendrocyte-associated enzyme in mouse brain. J. Neurochem. 57:95-102.
32. Wang, S., et al. 1996. Identification and characterization of Ich-3, a member of the interleukin-1beta converting enzyme (ICE)/Ced-3 family and an upstream regulator of ICE. J. Biol. Chem. 271:20580-20587.
33. Namura, S., et al. 1998. Activation and cleavage ot caspase-3 in apoptosis induced by experimental cerebral ischemia. J. Neurosci. 18:3659-3668.
34. Franklin, K.J.B., and Paxínos, G. 1997. The mouse brain streotaxic coordinates. Academic Press, San Diego, California, USA. ix-xiv.
35. Kendler, A., and Dawson, G. 1990, Progressive hypoxia inhibits the de novo synthesis of galactosylceramide in cultured oligodendrocytes. J. Biol. Chem. 265:12259-12266.
36. Liu, X., Kim, C.N., Yang, J., Jemmerson, R., and Wang, X. 1996. Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell. 86:147-157.
37. Zou, U., Henzel, W.J., Lin, X., Lutschg, A., and Wang, X. 1997. Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell. 90:405-413.
38. Kang, S.J., et al. 2000. Dual role of caspase-11 in mediating activation of caspase-1 and caspase-3 under pathological conditions. J. Cell. Biol. 149:613-622.
39. Casaccia-Bonnefil. P. 2000. Cell death in the oligodendrocyte lineage: a molecular perspective of life/death decisions in development and disease. Glia. 29:124-135.
40. Kumar, S. 1999. Mechanisms mediating caspase activation in cell death. Cell Death Differ. 6:1060-1066.
41. Nagata, S. 1997. Apoptosis by death factor. Cell. 88:355-365.
42. Li, H., Zhu, H., Xu, C.J., and Yuan, J. 1998. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell. 94:491-501.
43. Luo, X., Budihardjo, I., Zou, H., Slaughter, C., and Wang, X. 1998. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell. 94:481-490.
44. Irving, E.A., Yatsushiro, K., McCulloch, J., and Dewar, D. 1997. Rapid alteration of tau in oligodendrocytes after focal ischemic injury in the rat: involvement of free radicals. J. Cereb. Blood Flow Metab. 17:612-622.
45. Han, B.H., et al. 2000. BDNF blocks caspase-3 activation in neonatal hypoxia-ischemia. Neurobiol. Dis. 7:38-53.
46. Yoshida, T., Waeber, C., Huang, Z., and Moskowitz, M.A. 1995. Induction of nitric oxide synthase activity in rodent brain following middle cerebral artery occlusion. Neurosci. Lett. 194:214-218.
47. Eliasson, M.J., et al. 1999. Neuronal nitric oxide synthase activation and peroxynitrite formation in ischemic stroke linked to neural damage. J. Neurosci. 19:5910-5918.
48. Mitrovic, B., et al. 1995. Nitric oxide induces necrotic but not apoptotic cell death in oligodendrocytes. Neuroscience. 65:531-539.
49. Schulz, J.B., Weller, M., and Moskowitz, M.A. 1999. Caspases as treatment targets in stroke and neurodegenerative diseases. Ann. Neurol. 45:421-429.
50. Velier, J.J., et al. 1999. Caspase-8 and caspase-3 are expressed by different populations of cortical neurons undergoing delayed cell death after focal stroke in the rat. J. Neurosci. 19:5932-5941.
51. Garcia, J.H., et al. 1993. Progression from ischemic injury to infarct following middle cerebral artery occlusion in the rat. Am. J. Pathol. 142:623-635.